Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

A Majority of Patients Want AI to Improve Their Face Time With Physicians, ZS Research Finds

Posted by Paul Darling on Tue, Sep 25, 2018

Pratap Khedkar co-wrote this blog post, the second in a series on ZS’s 2018 AI in Healthcare study, with Paul Darling.

We trust artificial intelligence to navigate commuters around real-time traffic and pitch in when it’s time to cook dinner, and it’s even being called on to tackle the ever-looming laundry pile (for those who can afford the hefty price tag). AI also is well on its way to autonomously steering cars and landing airplanesalthough most consumers don’t feel comfortable completely foregoing human judgment when people’s lives are at stake.

We’ve found that that pretty much sums up how patients feel about AI’s potential role in healthcare delivery. They’re OK with AI taking on certain tasks, but they want the diagnoses and treatment decisions left in their physicians’ hands.

Read More

Topics: Patient Engagement, Paul Darling, artificial intelligence, data privacy, care delivery, healthcare administrative tasks, AI in Healthcare study, automated healthcare

Walking the Walk: How Pharma Companies Can Deliver Patient-Centric Experiences

Posted by Hensley Evans on Thu, Jul 12, 2018

The pharmaceutical industry has been talking about patient centricity for a long time, but despite having been a topic of great interest for more than a decade, there remains a lot of uncertainty about what being a truly patient-centric organization means. What does it mean to walk the walk and, more importantly, how can organizations ensure that a focus on patient centricity not only benefits patients but also drives business success?

Read More

Topics: patient experience, Pharma, Patient Engagement, eyeforpharma, insights, patient centricity, pharma companies, business outcomes

How Pharma Companies Are Engaging Patients as R&D Partners

Posted by Kristyn Feldman on Wed, Nov 08, 2017

Lisa Bance co-wrote this blog post with Kristyn Feldman.

This is the final post in a four-part series examining patient centricity within R&D.

To achieve true patient centricity in drug development, pharmaceutical companies need to follow four main principles: gain empathy for patients, uncover and meet patient needs, connect with patients and, finally, engage patients. By asking for and incorporating trial participant input at every level of R&D, the pharmaceutical industry can start to look at patients as true partners.

Read More

Topics: Big Pharma, Pharma, Patient Engagement, drug development, clinical trials, patient centricity, patient centricity in R&D, online patient network

How Technology and Analytics Are Helping Big Pharma Improve Patient Engagement in R&D

Posted by Kristyn Feldman on Wed, Nov 01, 2017

Lisa Bance co-wrote this blog post with Kristyn Feldman.

This is the third post in a four-part series examining patient centricity within R&D.

As drug development continues to grow more expensive and complex, and as patients expect to be more involved and empowered throughout the healthcare system, pharmaceutical companies are seeing the value in partnering with patients throughout the R&D process. The journey begins with building an understanding of and empathy for today’s patients, and then uncovering and meeting their needs. The third step is to hone in on how you connect with patients to increase the effectiveness of your communications.

Read More

Topics: Big Pharma, Analytics, Patient Engagement, drug development, medical technology, R&D, clinical trials, patient centricity, patient centricity in R&D, meet patient needs

How Biopharma Companies Are Working to Uncover and Meet Patient Needs

Posted by Kristyn Feldman on Wed, Oct 25, 2017

Lisa Bance co-wrote this blog post with Kristyn Feldman.

This is the second post in a four-part series examining patient centricity within R&D.

As pharmaceutical companies aim to make their drug development processes more patient-centric, we’ve noted that a formula for success is starting to emerge, and we’ve packaged that formula into our four pillars of patient centricity in R&D. In our last post, we addressed the first pillar: gaining an understanding of and empathy for patients. In this post, we review the second pillar: uncovering and meeting patients’ needs.

Read More

Topics: Pharma, Pharma Industry, Patient Engagement, drug development, co-creation, R&D, patient centricity, patient centricity in R&D, meet patient needs, collaborative communication

Subscribe to The Active Ingredient
SUBSCRIBE

Get 'THE ACTIVE INGREDIENT' Updates

Subscribe to receive email notifications whenever new blog posts are published.

×